Adult T-cell leukaemia-lymphoma (ATL) is a malignancy of peripheral T lymphocytes caused
by human T-lymphotropic virus type I (HTLV-1), and its prognosis is poor. There are an …

The etiology of the majority of human cancers is associated with a myriad of environmental
causes, including physical, chemical, and biological factors. DNA damage induced by such …

Purpose Adult T-cell leukemia-lymphoma (ATL) is usually resistant to conventional
chemotherapies, and there are few other treatment options. Because CC chemokine …

Adult T-cell leukemia-lymphoma (ATL) is a distinct peripheral T-lymphocytic malignancy
associated with a retrovirus designated human T-cell lymphotropic virus type I (HTLV-1). The …

Purpose Human T-cell lymphotropic virus type-I–associated adult T-cell leukemia/lymphoma
(ATL) is an aggressive, chemotherapy-resistant malignancy. Multiple small studies using …

Adult T-cell leukemia/lymphoma (ATL) is a highly aggressive T-cell malignancy that arises in
a proportion of individuals who are long-term carriers of human T-lymphotropic virus type 1 …

Adult T-cell leukemia/lymphoma (ATL) is an aggressive malignancy of mature activated T
cells caused by human T-cell lymphotropic virus type I. ATL carries a bad prognosis …

Adult T-cell leukemia/lymphoma (ATL) is resistant to chemotherapy and carries a dismal
prognosis particularly for the acute and lymphoma subtypes. Promising results were …

The peripheral T‐cell neoplasms are a biologically and clinically heterogeneous group of
rare disorders that result from clonal proliferation of mature post‐thymic lymphocytes …

Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused
by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of …